According to Dr Michael Khalil, Medical University of Graz, Austria, neurofilament light protein (sNfL) may be useful as a biomarker of age-related sub-clinical brain changes in normal healthy individuals as it can be relatively easily measured in serum. He described how increasing sNfL and increasing variability of levels in older people (>60 years) signifies an acceleration of neurodegeneration.
Changes in serum neurofilament light protein (sNfL) associated with normal aging
Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.